Autoimmunity in X-linked agammaglobulinemia: Kawasaki disease and review of the literature

References

• Winkelstein JA, Marino MC, Lederman HM et al. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore)85(4), 193–202 (2006).
   PubMed Web of Science ®Google Scholar
• Aghamohammadi A, Fiorini M, Moin M et al. Clinical, immunological and molecular characteristics of 37 Iranian patients with X-linked agammaglobulinemia. Int. Arch. Allergy Immunol.141(4), 408–414 (2006).
   PubMed Web of Science ®Google Scholar
• Moin M, Aghamohammadi A, Farhoudi A et al. X-linked agammaglobulinemia: a survey of 33 Iranian patients. Immunol. Invest.33(1), 81–93 (2004).
   PubMed Web of Science ®Google Scholar
• Tsukada S, Saffran DC, Rawlings DJ et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell72(2), 279–290 (1993).
   PubMed Web of Science ®Google Scholar
• Pessach IM. The relationship of x-linked primary immune deficiencies and autoimmunity. Curr. Allergy Asthma Rep.10(5), 311–319 (2010).
   PubMed Web of Science ®Google Scholar
• Kwan-Morley J, Albert D. B-cell inhibitors as therapy for rheumatoid arthritis: an update. Curr. Rheumatol. Rep.9(5), 401–406 (2007).
   PubMedGoogle Scholar
• Wilfert CM, Buckley RH, Mohanakumar T et al. Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia. N. Engl. J. Med.296(26), 1485–1489 (1977).
   PubMedGoogle Scholar
• Thyss A, El Baze P, Lefebvre JC, Schneider M, Ortonne JP. Dermatomyositis-like syndrome in X-linked hypogammaglobulinemia. Case-report and review of the literature. Acta Derm. Venereol.70(4), 309–313 (1990).
   PubMed Web of Science ®Google Scholar
• Barnett EV, Winkelstein A, Weinberger HJ. Agammaglobulinemia with polyarthritis and subcutaneous nodules. Am. J. Med.48(1), 40–47 (1970).
   PubMedGoogle Scholar
• Ochs HD, Notarangelo LD. X-linked immunodeficiencies. Curr. Allergy Asthma Rep.4(5), 339–348 (2004).
   PubMed Web of Science ®Google Scholar
• Howard V, Greene JM, Pahwa S et al. The health status and quality of life of adults with X-linked agammaglobulinemia. Clin. Immunol.118(2–3), 201–208 (2006).
   PubMed Web of Science ®Google Scholar
• Martin S, Wolf-Eichbaum D, Duinkerken G et al. Development of Type 1 diabetes despite severe hereditary B-lymphocyte deficiency. N. Engl. J. Med.345(14), 1036–1040 (2001).
   PubMed Web of Science ®Google Scholar
• Yoshino A, Honda M, Kanegane H et al. Membranoproliferative glomerulonephritis in a patient with X-linked agammaglobulinemia. Pediatr. Nephrol.21(1), 36–38 (2006).
   PubMedGoogle Scholar
• Notarangelo LD, Gambineri E, Badolato R. Immunodeficiencies with autoimmune consequences. Adv. Immunol.89, 321–370 (2006).
   PubMedGoogle Scholar
• Kawakami C, Miyake M, Tamai H. Kawasaki disease in a patient with Wiskott–Aldrich syndrome: an increase in the platelet count. Int. J. Hematol.77(2), 199–200 (2003).
   PubMedGoogle Scholar
• Yamazaki-Nakashimada MA, Ramirez-Vargas N, De Rubens-Figueroa J. Chronic granulomatous disease associated with atypical Kawasaki disease. Pediatr. Cardiol.29(1), 169–171 (2008).
   PubMedGoogle Scholar
• Gharib AM, Pettigrew RI, Elagha A et al. Coronary abnormalities in hyper-IgE recurrent infection syndrome: depiction at coronary MDCT angiography. AJR Am. J. Roentgenol.193(6), W478–W481 (2009).
   PubMedGoogle Scholar
• Ling JC, Freeman AF, Gharib AM et al. Coronary artery aneurysms in patients with hyper IgE recurrent infection syndrome. Clin. Immunol.122(3), 255–258 (2007).
   PubMedGoogle Scholar
• Bruton OC. Agammaglobulinemia. Pediatrics9(6), 722–728 (1952).
   PubMed Web of Science ®Google Scholar
• Bloom KA, Chung D, Cunningham-Rundles C. Osteoarticular infectious complications in patients with primary immunodeficiencies. Curr. Opin. Rheumatol.20(4), 480–485 (2008).
   PubMed Web of Science ®Google Scholar
• Hermaszewski R, Ratnavel R, Webster AD, Denman AM. Rheumatoid arthritis in a patient with primary hypogammaglobulinaemia. Br. J. Rheumatol.32(7), 636–639 (1993).
   PubMedGoogle Scholar
• Verbruggen G, De Backer S, Deforce D et al. X linked agammaglobulinaemia and rheumatoid arthritis. Ann. Rheum. Dis.64(7), 1075–1078 (2005).
   PubMed Web of Science ®Google Scholar
• Lee AH, Levinson AI, Schumacher HR Jr. Hypogammaglobulinemia and rheumatic disease. Semin. Arthritis Rheum.22(4), 252–264 (1993).
   PubMedGoogle Scholar
• Webster AD, Loewi G, Dourmashkin RD, Golding DN, Ward DJ, Asherson GL. Polyarthritis in adults with hypogammaglobulinaemia and its rapid response to immunoglobulin treatment. Br. Med. J.1(6021), 1314–1316 (1976).
   PubMedGoogle Scholar
• Ackerson BK, Raghunathan R, Keller MA, Bui RH, Phinney PR, Imagawa DT. Echovirus 11 arthritis in a patient with X-linked agammaglobulinemia. Pediatr. Infect. Dis. J.6(5), 485–488 (1987).
   PubMedGoogle Scholar
• Misbah SA, Spickett GP, Ryba PC et al. Chronic enteroviral meningoencephalitis in agammaglobulinemia: case report and literature review. J. Clin. Immunol.12(4), 266–270 (1992).
   PubMed Web of Science ®Google Scholar
• Etzioni A. Immune deficiency and autoimmunity. Autoimmun. Rev.2(6), 364–369 (2003).
   PubMed Web of Science ®Google Scholar
• Lehman HK, Ballow M. Immune deficiency disorders with autoimmunity and abnormalities in immune regulation-monogenic autoimmune diseases. Clin. Rev. Allergy Immunol.34(2), 141–145 (2008).
   PubMed Web of Science ®Google Scholar
• Galeotti C, Bayry J, Kone-Paut I, Kaveri SV. Kawasaki disease: aetiopathogenesis and therapeutic utility of intravenous immunoglobulin. Autoimmun. Rev.9(6), 441–448 (2010).
   PubMed Web of Science ®Google Scholar
• Alexoudi I, Kanakis M, Kapsimali V, Vaiopoulos G. Kawasaki disease: current aspects on aetiopathogenesis and therapeutic management. Autoimmun. Rev.10(9), 544–547 (2011).
   PubMedGoogle Scholar
• Dhillon R, Clarkson P, Donald AE et al. Endothelial dysfunction late after Kawasaki disease. Circulation94(9), 2103–2106 (1996).
   PubMedGoogle Scholar
• Falcini F, Trapani S, Turchini S et al. Immunological findings in Kawasaki disease: an evaluation in a cohort of Italian children. Clin. Exp. Rheumatol.15(6), 685–689 (1997).
   PubMedGoogle Scholar
• Grunebaum E, Blank M, Cohen S et al. The role of anti-endothelial cell antibodies in Kawasaki disease – in vitro and in vivo studies. Clin. Exp. Immunol.130(2), 233–240 (2002).
   PubMed Web of Science ®Google Scholar
• Rowley AH, Shulman ST, Spike BT, Mask CA, Baker SC. Oligoclonal IgA response in the vascular wall in acute Kawasaki disease. J. Immunol.166(2), 1334–1343 (2001).
   PubMed Web of Science ®Google Scholar
• Fukuhara K, Oikawa K, Amano T, Kusunoki T, Ochi Y. [Chronic thyroiditis associated with a decrease in the thyroid function and a skin condition in a 3-year-old girl]. Horumon To Rinsho25(8), 810–814 (1977).
   PubMedGoogle Scholar
• Hillyer CD, Schwenn MR, Fulton DR, Meissner HC, Berkman EM. Autoimmune hemolytic anemia in Kawasaki disease: a case report. Transfusion30(8), 738–740 (1990).
   PubMedGoogle Scholar
• Laxer RM, Cameron BJ, Silverman ED. Occurrence of Kawasaki disease and systemic lupus erythematosus in a single patient. J. Rheumatol.15(3), 515–516 (1988).
   PubMedGoogle Scholar
• Bhowmick SK, Estrada B, Rettig KR. Insulin-dependent diabetes mellitus in 2 male African American children after Kawasaki disease. Pediatrics110(2 Pt 1), e27 (2002).
   PubMedGoogle Scholar
• Stagi S, Simonini G, Ricci L, de Martino M, Falcini F. Coeliac disease in patients with Kawasaki disease. Is there a link? Rheumatology (Oxford)45(7), 847–850 (2006).
   PubMed Web of Science ®Google Scholar
• Hjelmstrom P. Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J. Leukoc. Biol.69(3), 331–339 (2001).
   PubMed Web of Science ®Google Scholar
• Furuno K, Yuge T, Kusuhara K et al. CD25+CD4+ regulatory T cells in patients with Kawasaki disease. J. Pediatr.145(3), 385–390 (2004).
   PubMed Web of Science ®Google Scholar
• Fairweather D, Kaya Z, Shellam GR, Lawson CM, Rose NR. From infection to autoimmunity. J. Autoimmun.16(3), 175–186 (2001).
   PubMed Web of Science ®Google Scholar
• Barnett LA, Fujinami RS. Molecular mimicry: a mechanism for autoimmune injury. FASEB J.6(3), 840–844 (1992).
   PubMed Web of Science ®Google Scholar
• Sleasman JW. The association between immunodeficiency and the development of autoimmune disease. Adv. Dent. Res.10(1), 57–61 (1996).
   PubMedGoogle Scholar
• Knight AK, Cunningham-Rundles C. Inflammatory and autoimmune complications of common variable immune deficiency. Autoimmun. Rev.5(2), 156–159 (2006).
   PubMed Web of Science ®Google Scholar
• Baccala R, Hoebe K, Kono DH, Beutler B, Theofilopoulos AN. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat. Med.13(5), 543–551 (2007).
   PubMed Web of Science ®Google Scholar
• Krieg AM, Vollmer J. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol. Rev.220, 251–269 (2007).
   PubMed Web of Science ®Google Scholar
• Kubo T, Uchida Y, Watanabe Y et al. Augmented TLR9-induced Btk activation in PIR-B-deficient B-1 cells provokes excessive autoantibody production and autoimmunity. J. Exp. Med.206(9), 1971–1982 (2009).
   PubMed Web of Science ®Google Scholar
• Rothlin CV, Ghosh S, Zuniga EI, Oldstone MB, Lemke G. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell131(6), 1124–1136 (2007).
   PubMed Web of Science ®Google Scholar
• Marsland BJ, Kopf M. Toll-like receptors: paving the path to T cell-driven autoimmunity? Curr. Opin. Immunol.19(6), 611–614 (2007).
   PubMedGoogle Scholar
• Doyle SL, Jefferies CA, Feighery C, O’Neill LA. Signaling by Toll-like receptors 8 and 9 requires Bruton’s tyrosine kinase. J. Biol. Chem.282(51), 36953–36960 (2007).
   PubMed Web of Science ®Google Scholar
• Lee KG, Xu S, Wong ET, Tergaonkar V, Lam KP. Bruton’s tyrosine kinase separately regulates NFkappaB p65RelA activation and cytokine interleukin (IL)-10/IL-12 production in TLR9-stimulated B cells. J. Biol. Chem.283(17), 11189–11198 (2008).
   PubMed Web of Science ®Google Scholar
• Baumgarth N, Tung JW, Herzenberg LA. Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Springer Semin. Immunopathol.26(4), 347–362 (2005).
   PubMed Web of Science ®Google Scholar
• Carroll MC, Holers VM. Innate autoimmunity. Adv. Immunol.86, 137–157 (2005).
   PubMed Web of Science ®Google Scholar
• Khan WN, Alt FW, Gerstein RM et al. Defective B cell development and function in Btk-deficient mice. Immunity3(3), 283–299 (1995).
   PubMed Web of Science ®Google Scholar
• Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol.3(2), 133–146 (2003).
   PubMed Web of Science ®Google Scholar
• Szabo SJ, Sullivan BM, Peng SL, Glimcher LH. Molecular mechanisms regulating Th1 immune responses. Annu. Rev. Immunol.21, 713–758 (2003).
   PubMed Web of Science ®Google Scholar
• Giordani L, Quaranta MG, Marchesi A et al. Increased frequency of immunoglobulin (Ig)A-secreting cells following Toll-like receptor (TLR)-9 engagement in patients with Kawasaki disease. Clin. Exp. Immunol.163(3), 346–353 (2011).
   PubMedGoogle Scholar